Who owns BENITEC BIOPHARMA INC?
- Ticker: BNTC
- CUSIP Number: 08205p209
Tip: Access positions for across all investors
Analyze quarterly positions in Benitec Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Benitec Biopharma stock
Who bought or sold BENITEC BIOPHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Franklin Resources | 588k | $3.0M | 0% | Mar 2024 |
|
Henderson Group | 245k | $1.3M | 36% | Mar 2024 |
|
Suvretta Capital Management | 204k | $1.1M | 0% | Mar 2024 |
|
Adage Capital Partners GP | 189k | $993k | 0% | Mar 2024 |
|
Vanguard Group | 17k | $88k | 0% | Mar 2024 |
|
Morgan Stanley | 12k | $62k | 100% | Mar 2024 |
|
Geode Capital Management | 10k | $51k | 0% | Mar 2024 |
|
GAMMA Investing | 3.6k | $19k | 955% | Mar 2024 |
|
Tower Research Capital | 1.7k | $9.2k | 790% | Mar 2024 |
|
UBS Group | 512.00 | $2.7k | -18% | Mar 2024 |
|
Rhumbline Advisers | 186.00 | $952.003800 | 0% | Mar 2024 |
|
Group One Trading | 89.00 | $456.000400 | 0% | Mar 2024 |
|
Wells Fargo & Company | 17.00 | $89.000100 | 0% | Mar 2024 |
|